Literature DB >> 15365047

Pathogenic differences between North American and Latin American strains of Histoplasma capsulatum var. capsulatum in experimentally infected mice.

Michelle M Durkin1, Patricia A Connolly, Kian Karimi, Emerson Wheat, Carol Schnizlein-Bick, Stephen D Allen, Katia Alves, Ram P Tewari, Elizabeth Keath.   

Abstract

Clinical differences in histoplasmosis between North America and Brazil prompted investigation of experimental infection with representative strains. Mortality was higher with Latin American strains, and lung pathology showed large necrotizing granuloma with prominent neutrophilic infiltration. Chronic disease was unique to the North American strain.

Entities:  

Mesh：

Year:  2004        PMID： 15365047      PMCID： PMC516292          DOI： 10.1128/JCM.42.9.4370-4373.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

1.  Chronic infection and reactivation in a pulmonary challenge model of histoplasmosis.

Authors:  M Durkin; S Kohler; C Schnizlein-Bick; A LeMonte; P Connolly; J Goldberg; T Garringer; L J Wheat
Journal:  J Infect Dis       Date:  2001-05-16       Impact factor: 5.226

2.  Differences in histoplasmosis in patients with acquired immunodeficiency syndrome in the United States and Brazil.

Authors:  Kian Karimi; L Joseph Wheat; Patricia Connolly; Gretchen Cloud; Rana Hajjeh; Emerson Wheat; Katia Alves; Carlos da Silva Lacaz Cd; Elizabeth Keath
Journal:  J Infect Dis       Date:  2002-11-05       Impact factor: 5.226

3.  Comparative studies with 18 strains of histoplasma; morphology in tissues and virulence of African and American strains.

Authors:  E DROUHET; J SCHWARZ
Journal:  J Lab Clin Med       Date:  1956-01

4.  Variability in virulence of strains of Histoplasma capsulatum.

Authors:  K L Anderson; S Marcus
Journal:  Am Rev Respir Dis       Date:  1969-04

5.  Typing of Histoplasma capsulatum by restriction fragment length polymorphisms in a nuclear gene.

Authors:  E J Keath; G S Kobayashi; G Medoff
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

6.  Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.

Authors:  P Connolly; J Wheat; C Schnizlein-Bick; M Durkin; S Kohler; M Smedema; J Goldberg; E Brizendine; D Loebenberg
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

7.  Phylogeography of the fungal pathogen Histoplasma capsulatum.

Authors:  Takao Kasuga; Thomas J White; Gina Koenig; Juan McEwen; Angela Restrepo; Elizabetha Castañeda; Carlos Da Silva Lacaz; Elisabeth M Heins-Vaccari; Roseli S De Freitas; Rosely M Zancopé-Oliveira; Zhenyu Qin; Ricardo Negroni; Deidre A Carter; Yuzuru Mikami; Miki Tamura; María Lucía Taylor; Georgina F Miller; Natteewan Poonwan; John W Taylor
Journal:  Mol Ecol       Date:  2003-12       Impact factor: 6.185
  7 in total
  13 in total

1.  High Mortality and Coinfection in a Prospective Cohort of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients with Histoplasmosis in Guatemala.

Authors:  Blanca Samayoa; Monika Roy; Angela Ahlquist Cleveland; Narda Medina; Dalia Lau-Bonilla; Christina M Scheel; Beatriz L Gomez; Tom Chiller; Eduardo Arathoon
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

2.  Detection of Latin American strains of Histoplasma in a murine model by use of a commercially available antigen test.

Authors:  David R Allton; Robert G Rivard; Patricia A Connolly; Suzanne McCall; Michelle M Durkin; Tonya M Boyd; Joseph P Flanagan; L Joseph Wheat; Duane R Hospenthal
Journal:  Clin Vaccine Immunol       Date:  2010-03-31

Review 3.  Histoplasma mechanisms of pathogenesis--one portfolio doesn't fit all.

Authors:  Jessica A Edwards; Chad A Rappleye
Journal:  FEMS Microbiol Lett       Date:  2011-08-09       Impact factor: 2.742

Review 4.  Considerations about the Geographic Distribution of Histoplasma Species.

Authors:  Maria Lucia Taylor; María Del Rocío Reyes-Montes; Daniel A Estrada-Bárcenas; Rosely M Zancopé-Oliveira; Gabriela Rodríguez-Arellanes; José Antonio Ramírez
Journal:  Appl Environ Microbiol       Date:  2022-03-09       Impact factor: 5.005

5.  Detection of Histoplasma capsulatum antigen in Panamanian patients with disseminated histoplasmosis and AIDS.

Authors:  Maria Eugenia Gutierrez; Alfredo Canton; Patricia Connolly; Robert Zarnowski; L Joseph Wheat
Journal:  Clin Vaccine Immunol       Date:  2008-02-20

6.  Two specific strains of Histoplasma capsulatum causing mucocutaneous manifestations of histoplasmosis: preliminary analysis of a frequent manifestation of histoplasmosis in southern Brazil.

Authors:  Luciano Z Goldani; Valério R Aquino; Luciano W Lunardi; Vanessa S Cunha; Rodrigo P Santos
Journal:  Mycopathologia       Date:  2008-12-27       Impact factor: 2.574

Review 7.  The use of genetic markers in the molecular epidemiology of histoplasmosis: a systematic review.

Authors:  L S Damasceno; T M J S Leitão; M L Taylor; M M Muniz; R M Zancopé-Oliveira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-11-20       Impact factor: 3.267

8.  Epidemiology of Invasive Fungal Infections in Latin America.

Authors:  Jose Sifuentes-Osornio; Dora E Corzo-León; L Alfredo Ponce-de-León
Journal:  Curr Fungal Infect Rep       Date:  2012-01-05

9.  Variation in thermal performance of a widespread pathogen, the amphibian chytrid fungus Batrachochytrium dendrobatidis.

Authors:  Lisa A Stevenson; Ross A Alford; Sara C Bell; Elizabeth A Roznik; Lee Berger; David A Pike
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

10.  Genome Sequences Reveal Cryptic Speciation in the Human Pathogen Histoplasma capsulatum.

Authors:  Victoria E Sepúlveda; Roberto Márquez; David A Turissini; William E Goldman; Daniel R Matute
Journal:  mBio       Date:  2017-12-05       Impact factor: 7.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.